Binding of primaquine to epidermal membranes and keratin

International Journal of Pharmaceutics

Volumn 257, Issue 1-2, 2003, Pages 237-244

  Heard, C M ^a   Monk, B V ^a   Modley, A J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Keratin; Primaquine; Skin; Stratum corneum

Indexed keywords

KERATIN; LIPID; MIGLYOL; PRIMAQUINE;

ARTICLE; BINDING AFFINITY; CATTLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BINDING SITE; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG SOLUTION; EPIDERMIS; EXPERIMENTAL MODEL; EXTRACTION; HUMAN; HUMAN TISSUE; MEMBRANE; MISCIBILITY; POWDER; PRIORITY JOURNAL; PROTEIN DOMAIN; SKIN CELL; STRATUM CORNEUM; TISSUE;

EID: 0037433786     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00140-6     Document Type: Article

References (25)

1. Abrams K., Harvell J., Shriner D., Wertz P., Maibach H.I., Rehfeld S. Effect of organic solvents on in vitro human skin water barrier function. Soc. Investig. Dermatol. 101:1993;609-613.
2. Artuc M., Reinhold C., Stuttgen G., Gazith J. A rapid method for measuring drug enrichment in epidermis. Arch. Dermatol. Res. 268:1980;129-140.
3. Banning T.P., Heard C.M. Binding of doxycycline to keratin, melanin and human epidermal tissue. Int. J. Pharm. 235:2002;219-227.
4. Chandrasekaran S.K., Campbell P.S., Watanabe T. Application of the 'dual sorption' model to drug transport through skin. Polym. Eng. Science. 20:1980;36-39.
5. Downing D.T. Lipid and protein structures in the permeability barrier of mammalian epidermis. J. Lipid Res. 33:1992;301-313.
6. Fedors R. A method for estimating both the solubility parameters and molar volumes of liquids. Polym. Eng. Sci. 14:1974;147-154.
7. Hashiguchi T., Kodama A., Ryu A., Otagiri M. Retention capacity of topical imidazole antifungal agents in the skin. Int. J. Pharm. 161:1998;195-204.
8. Idei T., Takahashi K., Nobuhara S., Miyachi Y. Cloning and characterization of a novel keratin binding protein, occulibin, which links keratin filaments to the nuclear envelope. J. Investig. Dermatol. 117:2001;135.
9. Jeans C.W., Heard C.M. A therapeutic dose of primaquine can be delivered across excised human skin from simple transdermal patches. Int. J. Pharm. 189:1999;1-6.
10. Kurz H., Fichtl B. Binding of drugs to tissues. Drug Metab. Rev. 14:2001;467-510.
11. Liron Z., Cohen S. Percutaneous absorption of alkanoic acids 1: a study of operational conditions. J. Pharm. Sci. 73:1984;534-537.
12. Mayorga P., Puisieux F., Courraze G. Formulation study of a transdermal delivery system of primaquine. Int. J. Pharm. 132:1996;71-79.
13. Menczel E., Maibach H.I. Chemical binding to human dermis in vitro testosterone and benzyl alcohol. Acta Dermatologica-Venereologica. 52:1972;38-42.
14. Menczel E., Bucks D., Maibach H.I., Wester R. Lindane binding to section of human skin: skin capacity and isotherm determinations. Ibid. 276:1984;326-329.
15. Morris, A., Kee, W.J., Brain, K.R., Heard, C.M., Watkinson, A.C., 1998. Vehicle effects in the permeation of primaquine across human skin in vitro. In: Brain, K.R., James, V.J., Walters, K. (Eds.), Perspectives in Percutaneous Penetration, vol. 5b. STS Publishing, Cardiff, pp. 180-182.
16. Osamura H., Jimbo Y., Ishihari M. Skin penetration of nicotinic acid, methyl nicotinate and butyl nicotinate in guinea pig. J. Dermatol. 11:1984;471-481.
17. Pellett M.A., Watkinson A.C., Hadgraft J., Brain K.R. Comparison of permeability data from traditional diffusion cells and ATR- FTIR spectroscopy. Part II. Determination of diffusional pathlengths in synthetic membranes and human stratum corneum. Int. J. Pharm. 154:1997;217-227.
18. Percot A., Lafleur M. Direct observation of domains in model stratum corneum lipid mixtures by Raman microspectroscopy. Biophys. J. 81:2001;2144-2153.
19. Perkins N.C., Heard C.M. In vitro dermal and transdermal delivery of doxycycline from ethanol/Miglyol 840. Int. J. Pharm. 190:1999;155-164.
20. Raykar P.V., Fung M., Anderson B.D. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm. Res. 5:1988;140-150.
21. Roberts M.S., Pugh W.J. Epidermal permeability: penetrant structure relationships. 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneaum. Int. J. Pharm. 132:1996;23-32.
22. Surber C., Wilhelm K.P., Hori M., Maibach H.I., Guy R.H. Optimisation of topical therapy. Partitioning of drugs into stratum corneum. Pharm. Res. 7:1990;1320-1324.
23. Walter K., Kurz H. Binding of drugs to human skin: influencing factors and the role of tissue lipids. J. Pharm. Pharmacol. 40:1988;689-693.
24. Wertz P.W., Downing D.T. Covalently bound omega - hydroxyacylsphingosine in the stratum corneum. Biochim. Biophys. Acta. 917:1987;108-111.
25. Yanagimoto G., Hayashi T., Hasegawa T., Seki T., Juni K., Sugibayashi K., Morimoto Y. Skin disposition of drugs after topical application in hairless rats. Chem. Pharm. Bull. 47:1999;749-754.